Posted March 10, 2014 by lorrainegenscript
For over a decade, the development of potent protease inhibitors, like the breakthrough drug Bortezomib, have been an important therapuetic strategy of cancer drug development.
Contact Email | [email protected] |
Issued By | lorraine xu |
Website | Immunoproteasome inhibitor treats multiple sclerosis |
Country | China |
Categories | Health |
Tags | health , inhibitor treats , peptide synthesis |
Last Updated | March 10, 2014 |